|
|
||||||||
Departments of Anesthesiology, Physiology and Biomedical Engineering, and Health Sciences Research, Mayo Clinic College of Medicine, Rochester Minnesota; and Department of Cardiology, First Affiliated Hospital, Medical School, Zhejiang University, Zhejiang, China
Submitted 20 June 2008 ; accepted in final form 26 August 2008
| ABSTRACT |
|---|
|
|
|---|
HR
20 beats/min, and low =
HR
10 beats/min; n = 15 per group). Peak HR during HUT was 87 ± 10 beats/min in the high and 69 ± 14 beats/min in the low group (P < 0.05). High HR responders had lower systolic pressure at baseline (121 ± 9 vs. 129 ± 11 mmHg, P < 0.05) and during HUT (120 ± 10 vs. 131 ± 13 mmHg, P < 0.05), and higher plasma norepinephrine (NE) response to HUT (
NE: 156.9 ± 17.8 vs. 89.0 ± 17.2 pg/ml; P < 0.05).
NE during HUT was also significantly correlated with
HR when all 76 subjects were included in a regression analysis (r = 0.39; P < 0.001). Pulse pressure was lower during HUT in high HR responders compared with low HR responders (45 ± 1 vs. 55 ± 2 mmHg, P < 0.05). High HR responders also had larger fluctuations in systolic and pulse pressure during HUT (coefficient of variation = 10.7 ± 0.7 vs. 5.7 ± 0.3%; 7.9 ± 0.5 vs. 4.1 ± 0.4%, respectively, P < 0.05). Sex distribution was different between groups (high: 5 women, 10 men; low: 10 women, 5 men). Higher HR with lower AP during HUT is consistent with normal baroreflex mechanisms of integration. Although interindividual variability appears to be a fundamental part of cardiovascular regulation, the mechanisms of these differences and the sex discrepancy requires further investigation. baroreflex; arterial pressure; orthostasis; sympathetic nervous system; norepinephrine
30 beats/min) to head-up tilt (HUT). These patients also present with symptoms of heart palpitations, dizziness, and headaches in the upright posture even when AP appears well maintained although less stable than "normal" (11, 15, 28). Potential mechanisms in POTS appear to include low blood volume, reduced stroke volume, impaired vasoconstriction, and reduced blood flow (11, 15, 28); however, the pathophysiology of this clinical syndrome is heterogeneous and not completely understood. For example, although POTS patients may exhibit anxious responses to their symptoms during upright posture, our laboratory previously showed that anxiety is not the cause of the excessive HR response to orthostasis in POTS patients (14). Furthermore, these patients showed normal baroreflex control of HR but greater fluctuations in systolic and pulse pressure (15). Other investigators have shown higher supine and upright plasma NE levels in POTS patients compared with healthy controls (11). Additionally, interventions that decrease effective circulating volume, such as bed rest deconditioning, can also create "POTS-like" conditions in which heart rate responses to orthostasis are augmented and blood pressure (BP) variability during tilt is also increased (27).
It is well known that orthostatic stress elicits a wide range of HR and AP responses among healthy individuals; this interindividual variability has been documented in previous work (1, 23, 24, 27). In the present study, we hypothesized that POTS is the extreme end of a continuum of cardiovascular responses to orthostasis and that healthy individuals with augmented HR response to HUT would exhibit cardiovascular dynamics during HUT that were more similar to POTS patients than healthy individuals with lower HR responses. We tested whether healthy individuals with a high HR response to HUT would have greater AP variability during HUT and higher plasma NE compared with individuals with low HR response.
| METHODS |
|---|
|
|
|---|
We then divided individuals into groups based on the extremes of HR responses. Those with a HR change
20 beats/min were classified as high HR responders, and those with a HR change
10 beats/min were classified as low HR responders. This resulted in 15 participants in each of the high and low HR responder groups, and 46 in the middle group. There were 10 men and 5 women among the high HR responders, 5 men and 10 women among the low HR responders, and 30 women and 16 men in the middle group.
Instrumentation. Subjects rested supine on a tilt table with a foot board while a 5-cm, 20-gauge catheter was inserted into the brachial artery of the nondominant arm using aseptic technique after local anesthesia (2% lidocaine). The catheter was connected to a pressure transducer for determination of AP. A three-lead electrocardiogram was used to measure HR continuously. A venous catheter was inserted in the dominant forearm for drug administration as part of the baroreceptor sensitivity (BRS) assessment.
BRS. After a 5-min baseline period, a bolus of sodium nitroprusside (100 µg) was given intravenously followed after 1 min by a bolus of phenylephrine (150 µg) to transiently decrease and increase AP, respectively. Data were recorded for an additional 2 min after the phenylephrine bolus. Recordings of AP and ECG were sampled at 250 Hz using data-acquisition software (Windaq, Dataq Instruments, Akron, OH) and stored on a computer for offline analysis with signal-processing software (Windaq, Dataq Instruments). Cardiac BRS was assessed using the relationship between R-R interval (RRI) and systolic pressure during the vasoactive drug boluses as described previously (4, 18).
HUT. We measured HR and AP (arterial catheter) during 5 min of 60° HUT after a period of 20 min of quiet supine rest. The average of 5 min baseline and HUT for HR and AP measurements is reported. These 5-min averages were used for calculation of the HR response to tilt; this difference was used to classify individuals as high or low HR responders, as described above. Arterial blood samples (5 ml) were taken during supine rest and during the last 30 s of HUT and transferred immediately to ice-chilled vacutainers containing anticoagulant and antioxidant. Participants then rested in the supine position for 10 min. Plasma was separated by refrigerated centrifugation and stored frozen until measured in reversed-phase high-performance liquid chromatography with electrochemical detection after extraction with activated alumina. Intra-assay coefficient of variation (CV) for NE was 4.5% at 224 pg/ml and 3.3% at 429 pg/ml, and interassay CV for NE was 7.9% at 49.3 pg/ml and 3.8% at 800 pg/ml.
Twenty-four hour BP and HR measurements. Twenty-four hour ambulatory BP and HR recordings (Spacelabs) were obtained. Monitors were set to record BP and HR every 15 min from 6 AM to 10 PM, and every 20 min from 10 PM to 6 AM. The daytime period was defined as the interval from 8 AM to 10 PM, and nighttime from midnight to 6 AM (21, 25). The night drop in BP was calculated as the difference between daytime and nighttime BP adjusted for the daytime BP level and expressed in percentages. The SDs and CVs of the 24-h recordings were used as an index of HR, systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure (PP) variability.
Statistical analysis. Means, SDs, and CVs were computed for all variables of interest during resting supine and during HUT. Independent t-tests were used to determine group differences in age, height, weight, body mass index (BMI), BRS, and 24-h BP assessments. One-way ANOVA was used to compare change in the HR, systolic arterial pressure (SAP), diastolic arterial pressure (DAP), PP, MAP, and NE from baseline to HUT between high, middle, and low HR responders. The average of the given variable over the 5 min of HUT was used for these analyses. To further assess potential difference over time, or between groups during HUT, a two-way repeated-measures ANOVA was used with group (high vs. low) as a between-subject effect and time as within-subject effect. We also performed regression analysis between the change in HR with HUT and BP and norepinephrine changes. An alpha < 0.05 was accepted as statistically significant. All analyses were done using SAS, version 9.1 (SAS Institute, Cary, NC) or Stata, version 9.1 (Stata, College Station, TX). Unless indicated otherwise, data are presented as means ± SE.
| RESULTS |
|---|
|
|
|---|
HR
20 beats/min) and low HR response to tilt (
HR
10 beats/min). General characteristics of low, middle, and high HR responders are shown in Table 1. Table 2 shows the sex distribution of the data for the subjects in the low and high HR responder groups. High HR responders were mostly men, while low HR responders were mostly women. Age, height, weight, BMI, and BRS were not different between groups. Mean 24-h HR, SBP, DBP, PP, and night percent drop in SBP were also not different between high and low HR responders; however, the CV for the 24-h HR and 24-h PP were significantly higher in the high HR responders (see Table 3).
|
|
|
|
|
HR when all 76 subjects were included in the analysis (r = 0.44, P < 0.0001). Moreover, there were significantly greater fluctuations in SAP and PP during HUT among the high HR responders compared with the low HR responders (see Table 1). However, these data did not show significant correlations when all 76 subjects were included in regression analysis.
|
| DISCUSSION |
|---|
|
|
|---|
The major cardiovascular reflex controlling BP during orthostasis is the arterial baroreflex. Supine cardiac BRS has been found to be similar between POTS and control subjects in previous studies (15); our present findings indicated no difference between high and low HR responders in terms of supine BRS in our healthy subjects as well. Another indication of appropriate baroreflex function in the present study was our observation that individuals with higher HR responses to tilt also had lower systolic pressures during tilt. That is, an appropriate baroreflex response would result in a higher HR when BP is lower.
Individuals with lower systolic pressure, and higher HR, during tilt also had a greater change in plasma NE during tilt. We found a significant positive correlation between the change in HR and the change in plasma NE during HUT across all 76 of our subjects (see Fig. 2). Sympathetic neurogenic vasoconstriction is quantitatively very important in terms of successful responses to orthostasis (5). Although we did not directly measure sympathetic nerve activity in the present study, this relationship suggests that those subjects "requiring" more of a HR response during HUT also had greater sympathetically mediated vasoconstriction.
Higher HRs during HUT may be related to low stroke volume as has been shown to occur during physical deconditioning in bed rest studies (15). Low stroke volume and physical deconditioning are also possible explanations for the fluctuations in SAP and PP (16). For example, it has been suggested that a steeper Frank-Starling relationship could be operating after bed rest deconditioning in people with smaller and less distensible hearts (13), meaning that small changes in left ventricular end-diastolic volume could provoke greater changes in stroke volume that are translated into greater variability in SAP and PP. Furthermore, in a randomized clinical trial, it was shown that 12 wk of moderate-intensity endurance exercise training intervention in young men with symptoms of orthostatic intolerance resulted in symptom improvement, increased stroke volume and total peripheral resistance, and HR and NE reductions during upright posture (29). It may be that our high HR responders, as well as actual patients with POTS, have some of the changes associated with less distensible hearts and/or physical deconditioning.
Data collected over a 24-h period provide comprehensive information regarding variability in systemic hemodynamics that may affect cardiovascular responses during activities of daily living. We were therefore interested to note that 24-h variability in HR and PP in our subjects was consistent with the data we collected during 5 min of HUT. The group with the high HR response to orthostasis demonstrated a greater CV in HR over a 24-h period. Consistent with the increased PP variability during orthostasis, this group also had a greater PP CV over 24 h. Although variability in these indexes has not been obtained by 24-h ambulatory BP monitoring in POTS patients, the findings in the present study are generally consistent with the idea that patients with clinical or preclinical orthostatic tachycardia exhibit a wider range of HR and PP throughout the circadian cycle.
Although we observed several similarities between our high HR responders and patients with POTS, it is important to emphasize that there were several important differences as well. For example, our participants did not have tachycardia as defined for the POTS syndrome (average HR at baseline and HUT was < 100 beats/min in our subjects), and they were asymptomatic during orthostasis. Our goal was to study healthy individuals with no tachycardia (and no symptoms) during upright posture and compare their cardiovascular dynamics with those of people with POTS; in this way we were able to emphasize the wide spectrum of human responses to orthostatic stress from asymptomatic to symptomatic.
We were surprised to note in the present study that most of the subjects with high HR responses to tilt were male. This contrasts with the typical 5:1 female-to-male ratio among POTS patients (11). Reduced stroke volume and/or cardiac filling are often primary causes of HR increases during orthostasis. Women have, on average, smaller hearts and lower blood volume compared with men (9); therefore, we expected more women than men among the high HR responders to HUT. Also, higher SAP and PP variability is more likely to occur in people with smaller hearts (16). Although we did not assess heart size in this study, we compared body size between the high and low HR responders, and no differences were observed in height and weight. Furthermore, within each group, the average height and weight of women were lower than in the men; therefore, it is unlikely that body size or perhaps heart size would be plausible explanations for the unexpected sex distribution in the high vs. low HR responders to tilt. With regard to sex comparison, a limitation of our study is that we did not identify specific subgroups of women who were taking oral contraceptives and compare them to those who were not. All women were studied in the low-hormone phase, such that hormonal influences should have been minimized, but specific comparisons of women taking oral contraceptives compared with normally menstruating women were not performed.
Thus the mechanistic basis for the sex distributions we observed remains unclear. Another possible explanation for the sex distribution among POTS patients could be related to women being more likely to report symptoms of orthostasis than men. It has been previously observed that, regardless of age or physical conditioning, women generally report more physical symptoms than men, a phenomenon not associated with psychological disorders (2, 12, 20). Although the sex differences we report may point to previously unidentified contributors to HR responses to tilt, further studies with larger sample sizes will be needed to further address this issue.
Another important difference between our participants and POTS patients was the level of plasma NE at baseline and during HUT. NE in POTS patients has been reported in the range of 154–309 pg/ml at baseline, and between 339 and 654 pg/ml during HUT (28). In our participants, plasma NE values ranged between 53 and 198 pg/ml at baseline, and between 110 and 534 pg/ml during HUT. However, eight of our participants at baseline (3 high HR responders and 5 low HR responders) and six during HUT (4 high HR responders and 2 low HR responders) had NE values within the range reported in POTS patients. Although higher plasma NE levels are expected from the activation of the sympathetic system during orthostasis, the exaggerated NE response in POTS patients could be not just the result of a higher NE spillover but also a possible reduced NE clearance (17). The impact of having high levels of NE circulating for a longer period of time in the pathophysiology of POTS is not clear, especially when the symptoms and the HR increment during HUT do not appear to be related to standing NE levels of 600 pg/ml or higher (28). The interindividual variability in plasma NE and the number of factors that can affect this value (release, reuptake, metabolism, etc.) make the contribution of this variable difficult to evaluate.
In the context of measuring cardiovascular responses to tilt, it is of interest to note that invasive instrumentation (such as the arterial and intravenous catheters used in this study) has been shown to be associated with decreases in orthostatic tolerance in cross-sectional analyses (6, 7, 26). Thus it is possible that the invasive nature of our studies may have increased the overall rate of presyncope in our study. In this context, five subjects exhibited symptoms of presyncope in our study and were excluded from further analysis. We used direct arterial catheterization as the most accurate method of measuring beat-to-beat arterial pressure, and we do not believe this affects our present conclusions since all subjects were similarly instrumented.
In summary, we report in the present study that individuals with higher HR responses during HUT exhibit several cardiovascular responses that are similar to those seen in POTS patients. In high HR responders, the BP variability and the plasma NE responses were all greater than those exhibited by individuals with lower HR responses. Our goal was to investigate the spectrum of cardiovascular responses within a healthy, asymptomatic population. In this context, therefore, it is important to emphasize that our high HR responders had several important differences from POTS patients as well: they were asymptomatic, and HR and plasma NE values were below those reported in POTS. Nonetheless, the similarities between our high HR responders and POTS patients add an additional step in our understanding of the pathophysiology of the syndrome. Future work investigating the role of interindividual variability in autonomic regulation of BP is needed to continue to provide insight into these important questions.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. Thorin and N. Thorin-Trescases Vascular endothelial ageing, heartbeat after heartbeat Cardiovasc Res, October 1, 2009; 84(1): 24 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Thomas, J. D. Cotter, S. D. Galvin, M. J. A. Williams, C. K. Willie, and P. N. Ainslie Initial orthostatic hypotension is unrelated to orthostatic tolerance in healthy young subjects J Appl Physiol, August 1, 2009; 107(2): 506 - 517. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |